Breaking News Instant updates and real-time market news.

VIV

Telefonica Brasil

$8.86 /

-0.27 (-2.96%)

05:45
04/22/20
04/22
05:45
04/22/20
05:45

Telefonica Brasil upgraded to Overweight from Neutral at JPMorgan

JPMorgan analyst Marcelo Santos upgraded Telefonica Brasil to Overweight from Neutral with a R$58 price target.

  • 06

    May

VIV Telefonica Brasil
$8.86 /

-0.27 (-2.96%)

04/01/20 Goldman Sachs
Telefonica Brasil upgraded to Buy from Neutral at Goldman Sachs
04/01/20 Goldman Sachs
Telefonica Brasil upgraded to Buy from Neutral at Goldman Sachs
08/01/19 Barclays
Barclays upgrades Tim Participacoes to Overweight, downgrades Telefonica Brasil
08/01/19 Barclays
Telefonica Brasil downgraded to Equal Weight from Overweight at Barclays

TODAY'S FREE FLY STORIES

Hot Stocks
Ortho Clinical Diagnostics new COVID tests receive CE Mark » 08:07
03/08/21
03/08
08:07
03/08/21
08:07
OCDX

Ortho Clinical Diagnostics

$16.49 /

+0.385 (+2.39%)

Ortho Clinical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OCDX Ortho Clinical Diagnostics
$16.49 /

+0.385 (+2.39%)

03/02/21 Barclays
Ortho Clinical Diagnostics initiated with an Overweight at Barclays
03/02/21 Barclays
Ortho Clinical Diagnostics initiated with an Overweight at Barclays
02/22/21
Fly Intel: Top five analyst initiations
02/22/21 Evercore ISI
Ortho Clinical Diagnostics initiated with an Outperform at Evercore ISI
  • 28
    Jan
OCDX Ortho Clinical Diagnostics
$16.49 /

+0.385 (+2.39%)

OCDX Ortho Clinical Diagnostics
$16.49 /

+0.385 (+2.39%)

Hot Stocks
Iteris initiates review of alternatives » 08:06
03/08/21
03/08
08:06
03/08/21
08:06
ITI

Iteris

$5.79 /

-0.32 (-5.24%)

Iteris announced that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ITI Iteris
$5.79 /

-0.32 (-5.24%)

ITI Iteris
$5.79 /

-0.32 (-5.24%)

03/02/21 Northland
Rekor unlikely to increase offer for Iteris, says Northland
12/08/20 B. Riley Securities
Iteris price target raised to $9 from $8.50 at B. Riley Securities
ITI Iteris
$5.79 /

-0.32 (-5.24%)

Hot Stocks
Pluralsight, Vista Equity Partners amend agreement to $22.50 per share » 08:06
03/08/21
03/08
08:06
03/08/21
08:06
PS

Pluralsight

$20.59 /

-0.21 (-1.01%)

Pluralsight and Vista…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PS Pluralsight
$20.59 /

-0.21 (-1.01%)

PS Pluralsight
$20.59 /

-0.21 (-1.01%)

01/04/21 Truist
Pluralsight downgraded to Hold from Buy at Truist
01/04/21 Truist
Pluralsight downgraded to Hold from Buy at Truist
12/17/20 Barclays
Pluralsight downgraded to Equal Weight from Overweight at Barclays
12/15/20 Baird
Pluralsight downgraded to Neutral from Outperform at Baird
PS Pluralsight
$20.59 /

-0.21 (-1.01%)

  • 10
    Jun
PS Pluralsight
$20.59 /

-0.21 (-1.01%)

PS Pluralsight
$20.59 /

-0.21 (-1.01%)

PS Pluralsight
$20.59 /

-0.21 (-1.01%)

Initiation
Adagene initiated with a Buy at Jefferies » 08:06
03/08/21
03/08
08:06
03/08/21
08:06
ADAG

Adagene

$23.05 /

+0.39 (+1.72%)

Jefferies analyst Kelly…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADAG Adagene
$23.05 /

+0.39 (+1.72%)

07:18 Today Morgan Stanley
Adagene initiated with an Overweight at Morgan Stanley
03/06/21 Goldman Sachs
Adagene initiated with a Buy at Goldman Sachs
  • 09
    Feb
ADAG Adagene
$23.05 /

+0.39 (+1.72%)

Hot Stocks
Molecular Data reaches partnership memorandum for a potential transaction » 08:05
03/08/21
03/08
08:05
03/08/21
08:05
MKD

Molecular Data

$1.25 /

+0.185 (+17.45%)

Molecular Data announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MKD Molecular Data
$1.25 /

+0.185 (+17.45%)

Recommendations
Cheniere Energy price target raised to $86 from $69 at Credit Suisse » 08:05
03/08/21
03/08
08:05
03/08/21
08:05
LNG

Cheniere Energy

$72.57 /

-0.52 (-0.71%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LNG Cheniere Energy
$72.57 /

-0.52 (-0.71%)

LNG Cheniere Energy
$72.57 /

-0.52 (-0.71%)

02/01/21 Scotiabank
Cheniere Energy Partners downgraded to Sector Perform from Outperform at Scotiabank
01/28/21 Wells Fargo
Cheniere Energy price target raised to $77 from $70 at Wells Fargo
01/13/21 JPMorgan
JPMorgan announces top 10 energy picks for 2021
01/11/21 Raymond James
Cheniere Energy upgraded to Strong Buy from Outperform at Raymond James
LNG Cheniere Energy
$72.57 /

-0.52 (-0.71%)

LNG Cheniere Energy
$72.57 /

-0.52 (-0.71%)

Hot Stocks
Henry Schein reinstates share repurchase program » 08:05
03/08/21
03/08
08:05
03/08/21
08:05
HSIC

Henry Schein

$62.62 /

+1.12 (+1.82%)

Henry Schein announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HSIC Henry Schein
$62.62 /

+1.12 (+1.82%)

HSIC Henry Schein
$62.62 /

+1.12 (+1.82%)

02/18/21 Barrington
Henry Schein price target raised to $80 from $72 at Barrington
02/17/21 Piper Sandler
Henry Schein investors should take advantage of pullback, says Piper Sandler
02/08/21 Piper Sandler
Henry Schein assumed with an Overweight at Piper Sandler
01/04/21 Baird
Henry Schein upgraded to Outperform at Baird on recovery potential
HSIC Henry Schein
$62.62 /

+1.12 (+1.82%)

Hot Stocks
Sesen Bio submits MAA to EMA for Vicineum » 08:04
03/08/21
03/08
08:04
03/08/21
08:04
SESN

Sesen Bio

$2.43 /

-0.005 (-0.21%)

Sesen Bio announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SESN Sesen Bio
$2.43 /

-0.005 (-0.21%)

SESN Sesen Bio
$2.43 /

-0.005 (-0.21%)

02/17/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Jefferies
Jefferies doubles target on Sesen Bio to $6 on 'optimal scenario'
01/25/21 Canaccord
Sesen Bio a must-own small cap for 2021, says Canaccord
SESN Sesen Bio
$2.43 /

-0.005 (-0.21%)

Hot Stocks
Caladrius announces Orphan Drug Designation for CLBS12 » 08:04
03/08/21
03/08
08:04
03/08/21
08:04
CLBS

Caladrius

$1.78 /

-0.025 (-1.39%)

Caladrius Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLBS Caladrius
$1.78 /

-0.025 (-1.39%)

CLBS Caladrius
$1.78 /

-0.025 (-1.39%)

03/03/21 Brookline
Caladrius price target raised to $10 from $7 at Brookline
01/19/21 H.C. Wainwright
Caladrius price target lowered to $14 from $18.50 at H.C. Wainwright
05/22/20 Brookline
Caladrius initiated with a Buy at Brookline
05/18/20 Dawson James
Caladrius downgraded to Neutral from Buy at Dawson James
CLBS Caladrius
$1.78 /

-0.025 (-1.39%)

CLBS Caladrius
$1.78 /

-0.025 (-1.39%)

Recommendations
Soliton's multiple 2021 trials to expand its pipeline, says Maxim » 08:04
03/08/21
03/08
08:04
03/08/21
08:04
SOLY

Soliton

$12.85 /

+0.45 (+3.63%)

Maxim analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SOLY Soliton
$12.85 /

+0.45 (+3.63%)

SOLY Soliton
$12.85 /

+0.45 (+3.63%)

02/08/21 Maxim
Soliton price target raised to $25 from $22 at Maxim
02/02/21 Cantor Fitzgerald
Soliton price target raised to $20 from $12 at Cantor Fitzgerald
07/15/20 Cantor Fitzgerald
Soliton initiated with an Overweight at Cantor Fitzgerald
06/16/20 Roth Capital
Soliton price target raised to $16 from $14 at Roth Capital
SOLY Soliton
$12.85 /

+0.45 (+3.63%)

  • 26
    Jun
Hot Stocks
Atlas Corp. announces joint venture with Zhejiang Energy Group » 08:04
03/08/21
03/08
08:04
03/08/21
08:04
ATCO

Atlas Corp.

$14.11 /

+0.1 (+0.71%)

Atlas Corp. announced,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATCO Atlas Corp.
$14.11 /

+0.1 (+0.71%)

ATCO Atlas Corp.
$14.11 /

+0.1 (+0.71%)

02/04/21 B. Riley Securities
Atlas Corp. initiated with a Buy, $16.50 target at B. Riley
02/04/21 B. Riley Securities
Atlas Corp. initiated with a Buy at B. Riley Securities
12/07/20 Stifel
Atlas Corp. price target raised to $11 from $9.50 at Stifel
10/30/20 BMO Capital
Atlas Corp. price target lowered to C$46 from C$47 at BMO Capital
Conference/Events
CytoDyn to hold an investment community webcast » 08:03
03/08/21
03/08
08:03
03/08/21
08:03
CYDY

CytoDyn

$0.00 /

+ (+0.00%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CYDY CytoDyn
$0.00 /

+ (+0.00%)

CYDY CytoDyn
$0.00 /

+ (+0.00%)

07/06/20 H.C. Wainwright
CytoDyn downgraded to Neutral from Buy at H.C. Wainwright
04/28/20 H.C. Wainwright
CytoDyn price target raised to $4 from $3 at H.C. Wainwright
04/03/20 H.C. Wainwright
CytoDyn price target raised to $3 from $1.50 at H.C. Wainwright
Earnings
Ardelyx reports Q4 EPS (32c), consensus (26c) » 08:03
03/08/21
03/08
08:03
03/08/21
08:03
ARDX

Ardelyx

$6.68 /

+0.005 (+0.07%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARDX Ardelyx
$6.68 /

+0.005 (+0.07%)

ARDX Ardelyx
$6.68 /

+0.005 (+0.07%)

01/21/21 Piper Sandler
Ardelyx remains a top pick into April PDUFA at Piper Sandler
01/05/21 Cantor Fitzgerald
Ardelyx initiated with an Overweight at Cantor Fitzgerald
12/11/20 SVB Leerink
Ardelyx price target raised to $14 from $11 at SVB Leerink
10/20/20 Citi
Ardelyx transferred with Buy rating, $13 target at Citi
ARDX Ardelyx
$6.68 /

+0.005 (+0.07%)

ARDX Ardelyx
$6.68 /

+0.005 (+0.07%)

Hot Stocks
Iqvia collaborates with Janssen on COVID-19 vaccine clinical trials » 08:03
03/08/21
03/08
08:03
03/08/21
08:03
IQV

Iqvia

$188.91 /

+2.44 (+1.31%)

, JNJ

Johnson & Johnson

$156.09 /

+3.09 (+2.02%)

Iqvia (IQV) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IQV Iqvia
$188.91 /

+2.44 (+1.31%)

JNJ Johnson & Johnson
$156.09 /

+3.09 (+2.02%)

IQV Iqvia
$188.91 /

+2.44 (+1.31%)

06:40 Today KeyBanc
Iqvia upgraded to Overweight from Sector Weight at KeyBanc
03/02/21 Barclays
Iqvia initiated with an Overweight at Barclays
03/02/21 Barclays
Iqvia initiated with an Overweight at Barclays
02/11/21 Truist
Iqvia price target raised to $235 from $197 at Truist
JNJ Johnson & Johnson
$156.09 /

+3.09 (+2.02%)

02/10/21 BTIG
Model N upgraded to Buy from Neutral at BTIG
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
02/01/21 Wells Fargo
Moderna price target raised to $145 from $129 at Wells Fargo
02/01/21 BofA
BofA downgrades Moderna to Underperform, sees shares priced for 'best-case'
IQV Iqvia
$188.91 /

+2.44 (+1.31%)

JNJ Johnson & Johnson
$156.09 /

+3.09 (+2.02%)

JNJ Johnson & Johnson
$156.09 /

+3.09 (+2.02%)

IQV Iqvia
$188.91 /

+2.44 (+1.31%)

JNJ Johnson & Johnson
$156.09 /

+3.09 (+2.02%)

IQV Iqvia
$188.91 /

+2.44 (+1.31%)

JNJ Johnson & Johnson
$156.09 /

+3.09 (+2.02%)

Initiation
Bumble initiated with a Buy at Jefferies » 08:02
03/08/21
03/08
08:02
03/08/21
08:02
BMBL

Bumble

$61.93 /

+2.41 (+4.05%)

Jefferies analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMBL Bumble
$61.93 /

+2.41 (+4.05%)

08:02 Today Jefferies
Bumble initiated with a Buy at Jefferies
07:30 Today JPMorgan
Bumble initiated with a Neutral at JPMorgan
07:30 Today Cowen
Bumble initiated with an Outperform at Cowen
06:53 Today Morgan Stanley
Bumble initiated with an Equal Weight at Morgan Stanley
  • 11
    Feb
BMBL Bumble
$61.93 /

+2.41 (+4.05%)

BMBL Bumble
$61.93 /

+2.41 (+4.05%)

Hot Stocks
AnaptysBio says imsidolimab POPLAR Phase 2 trial did not meet primary endpoint » 08:02
03/08/21
03/08
08:02
03/08/21
08:02
ANAB

AnaptysBio

$29.46 /

+1.33 (+4.73%)

AnaptysBio announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANAB AnaptysBio
$29.46 /

+1.33 (+4.73%)

ANAB AnaptysBio
$29.46 /

+1.33 (+4.73%)

02/11/21 JPMorgan
JPMorgan double upgrades AnaptysBio, more than doubles price target
02/11/21 JPMorgan
AnaptysBio upgraded to Overweight from Underweight at JPMorgan
10/27/20
Fly Intel: Top five analyst upgrades
10/27/20 Truist
AnaptysBio price target raised to $27 from $20 at Truist
ANAB AnaptysBio
$29.46 /

+1.33 (+4.73%)

ANAB AnaptysBio
$29.46 /

+1.33 (+4.73%)

Initiation
Lufax initiated with a Buy at Citi » 08:02
03/08/21
03/08
08:02
03/08/21
08:02
LU

Lufax

$15.24 /

+0.01 (+0.07%)

Citi analyst Judy Zhang…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LU Lufax
$15.24 /

+0.01 (+0.07%)

LU Lufax
$15.24 /

+0.01 (+0.07%)

12/11/20 China Renaissance
Lufax initiated with a Buy at China Renaissance
11/27/20 HSBC
Lufax initiated with a Buy at HSBC
11/24/20
Fly Intel: Top five analyst initiations
11/24/20 Stifel
Lufax initiated with a Hold at Stifel
LU Lufax
$15.24 /

+0.01 (+0.07%)

  • 30
    Oct
LU Lufax
$15.24 /

+0.01 (+0.07%)

LU Lufax
$15.24 /

+0.01 (+0.07%)

Recommendations
Crane price target raised to $100 from $96 at Canaccord » 08:00
03/08/21
03/08
08:00
03/08/21
08:00
CR

Crane

$89.46 /

+2.7 (+3.11%)

Canaccord analyst Ken…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CR Crane
$89.46 /

+2.7 (+3.11%)

01/07/21 Vertical Research
Crane upgraded to Buy with $97 price target at Vertical Research
01/07/21 DA Davidson
Crane cut to Neutral at DA Davidson on valuation
01/07/21 DA Davidson
Crane downgraded to Neutral from Buy at DA Davidson
10/07/20 DA Davidson
DA Davidson positive on Crane's Engineered Materials, PMT segments
CR Crane
$89.46 /

+2.7 (+3.11%)

CR Crane
$89.46 /

+2.7 (+3.11%)

Options
NIO call buyer realizes 65% same-day gains » 08:00
03/08/21
03/08
08:00
03/08/21
08:00
NIO

NIO

$38.13 /

-1.135 (-2.89%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NIO NIO
$38.13 /

-1.135 (-2.89%)

NIO NIO
$38.13 /

-1.135 (-2.89%)

03/03/21 Wedbush
China growth story worth at least $100/share in bull case to Tesla, says Wedbush
02/26/21 HSBC
NIO price target raised to $54 from $44.70 at HSBC
02/09/21 Deutsche Bank
NIO job post shows ambitions to enter U.S. market, says Deutsche Bank
01/28/21 Morgan Stanley
NIO price target raised to $80 from $33 at Morgan Stanley
NIO NIO
$38.13 /

-1.135 (-2.89%)

  • 14
    Dec
  • 31
    Aug
  • 11
    Jun
NIO NIO
$38.13 /

-1.135 (-2.89%)

NIO NIO
$38.13 /

-1.135 (-2.89%)

NIO NIO
$38.13 /

-1.135 (-2.89%)

Recommendations
Imara price target lowered to $42 from $59 at SVB Leerink » 07:58
03/08/21
03/08
07:58
03/08/21
07:58
IMRA

Imara

$10.00 /

-2.37 (-19.16%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMRA Imara
$10.00 /

-2.37 (-19.16%)

IMRA Imara
$10.00 /

-2.37 (-19.16%)

01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
08/17/20
Fly Intel: Top five analyst upgrades
08/17/20 Citi
Imara upgraded to Buy from Neutral at Citi
06/30/20 Citi
Imara downgraded to Neutral from Buy at Citi
IMRA Imara
$10.00 /

-2.37 (-19.16%)

  • 12
    Mar
IMRA Imara
$10.00 /

-2.37 (-19.16%)

Downgrade
GSX Techedu downgraded to Sell from Outperform at CLSA » 07:58
03/08/21
03/08
07:58
03/08/21
07:58
GSX

GSX Techedu

$92.25 /

+8.14 (+9.68%)

CLSA analyst Jeffrey Chan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GSX GSX Techedu
$92.25 /

+8.14 (+9.68%)

GSX GSX Techedu
$92.25 /

+8.14 (+9.68%)

07:38 Today JPMorgan
GSX Techedu price target lowered to $60 from $63 at JPMorgan
02/01/21 JPMorgan
GSX Techedu downgraded to Underweight from Neutral at JPMorgan
01/29/21
GSX Techedu downgraded to Sell from Neutral at China Merchants
01/28/21 Goldman Sachs
GSX Techedu downgraded to Sell from Neutral at Goldman Sachs
GSX GSX Techedu
$92.25 /

+8.14 (+9.68%)

GSX GSX Techedu
$92.25 /

+8.14 (+9.68%)

GSX GSX Techedu
$92.25 /

+8.14 (+9.68%)

GSX GSX Techedu
$92.25 /

+8.14 (+9.68%)

Hot Stocks
AnaptysBio trading halted, news pending  07:55
03/08/21
03/08
07:55
03/08/21
07:55
ANAB

AnaptysBio

$29.46 /

+1.33 (+4.73%)

 
ShowHide Related Items >><<
ANAB AnaptysBio
$29.46 /

+1.33 (+4.73%)

ANAB AnaptysBio
$29.46 /

+1.33 (+4.73%)

02/11/21 JPMorgan
JPMorgan double upgrades AnaptysBio, more than doubles price target
02/11/21 JPMorgan
AnaptysBio upgraded to Overweight from Underweight at JPMorgan
10/27/20
Fly Intel: Top five analyst upgrades
10/27/20 Truist
AnaptysBio price target raised to $27 from $20 at Truist
ANAB AnaptysBio
$29.46 /

+1.33 (+4.73%)

ANAB AnaptysBio
$29.46 /

+1.33 (+4.73%)

Hot Stocks
Baker Bros Advisors report 9.9% stake in Aeglea BioTherapeutics » 07:54
03/08/21
03/08
07:54
03/08/21
07:54
AGLE

Aeglea BioTherapeutics

$7.21 /

+0.06 (+0.84%)

In a regulatory 13D…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AGLE Aeglea BioTherapeutics
$7.21 /

+0.06 (+0.84%)

AGLE Aeglea BioTherapeutics
$7.21 /

+0.06 (+0.84%)

01/05/21 H.C. Wainwright
Aeglea delays trial enrollment goal by two months, says H.C. Wainwright
12/22/20 Piper Sandler
Aeglea BioTherapeutics named a top pick for 2021 at Piper Sandler
08/10/20 Piper Sandler
Piper Sandler backs Overweight rating on Aeglea BioTherapeutics after Q2 results
05/04/20
Fly Intel: Top five analyst initiations
AGLE Aeglea BioTherapeutics
$7.21 /

+0.06 (+0.84%)

  • 28
    Apr
Upgrade
Surge Energy upgraded to Buy from Hold at Stifel » 07:52
03/08/21
03/08
07:52
03/08/21
07:52
ZPTAF

Surge Energy

$0.00 /

+ (+0.00%)

Stifel analyst Robert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZPTAF Surge Energy
$0.00 /

+ (+0.00%)

03/07/21 National Bank
Surge Energy upgraded to Outperform from Sector Perform at National Bank
02/19/21 National Bank
Surge Energy price target raised to C$0.75 from C$0.50 at National Bank
01/28/21 Stifel
Surge Energy price target raised to C$0.45 from C$0.40 at Stifel
01/06/21 National Bank
Surge Energy price target raised to C$0.50 from C$0.40 at National Bank
Hot Stocks
OpGen announces publication of study results of Unyvero HPN panel » 07:51
03/08/21
03/08
07:51
03/08/21
07:51
OPGN

OpGen

$1.94 /

+0.14 (+7.78%)

OpGen announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OPGN OpGen
$1.94 /

+0.14 (+7.78%)

OPGN OpGen
$1.94 /

+0.14 (+7.78%)

03/02/21 Alliance Global Partners
Alliance Global raises OpGen price target to $7, sees 'eventful 2021'
11/13/20 Alliance Global Partners
OpGen price target raised to $5.65 from $5.00 at Alliance Global Partners
06/09/20 Alliance Global Partners
Alliance Global Partners sees OpGen preliminary data as positive
06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
OPGN OpGen
$1.94 /

+0.14 (+7.78%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.